A phase 1 study evaluating the safety, pharmacokinetics, and efficacy of ABT-263 in subjects with refractory or relapsed lymphoid malignancies Meeting Abstract
| Authors: | Wilson, W. H.; Czuczman, M. S.; LaCasce, A. S.; Gerecitano, J. F.; Leonard, J. P.; Dunleavy, K.; Krivoshik, A. P.; Xiong, H.; Chiu, Y.; O'Connor, O. A. |
| Abstract Title: | A phase 1 study evaluating the safety, pharmacokinetics, and efficacy of ABT-263 in subjects with refractory or relapsed lymphoid malignancies |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 456s |
| Language: | English |
| ACCESSION: | WOS:000208457403039 |
| DOI: | 10.1200/jco.2008.26.15_suppl.8511 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8511 -- Source: Wos |
